Background Limb-Girdle Muscular Dystrophy (LGMD) is a rare heterogeneous group of neuromuscular disorders distinguished by progressive weakness of limb-girdle muscles. Diagnosis of LGMD is a challenging task and requires multiple obligatory assays.
Objective To study the epidemiology, clinical features, the genetic variability in patients diagnosed with LGMD through Next Generation Sequencing.
Material and Method A retrospective study of 27 patients suspected of LGMD was done to study the phenotypic presentation and the genotypic alteration of the patients, presenting to a tertiary care center in Rajasthan were studied.
Results Out of the twenty-seven patients suspected of LGMD, nineteen patients took genetic tests, while eight patients underwent biopsy. Among the nineteen patients, seventeen patients were identified with pathogenic mutations. Autosomal Recessive (LGMD-R) was the most common subgroup in this cohort. In the LGMD R1 subgroup, the most common mutation was c.2051-1 G>T and the exon hotspot was 18-22. The deleterious mutations in the LGMD R2 subgroup were distributed along the entire coding sequence, without any hotspot. However, C2E, C2F, and DysF domains contain variants at higher frequencies. The types of mutations were mostly point mutations (34 % of missense mutations and 66 % of nonsense mutations). We identified one novel mutation which was considered as a stop codon. Patients(n = 8) who underwent muscle biopsy for immunohistochemistry, had absent/reduced sarcoglycan uptake (n = 4) or absent dysferlin (n = 2) on the sarcolemma, while the remaining two biopsies were inconclusive (due to multiple protein deficiencies).
Conflict of interest
Nil.
Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at doi:10.1016/j.gmg.2024.100035.
| [1] |
Encyclopedia of the Neurological Sciences. 2014. Google Books. Academic Press. 〈 https://books.google.co.in/books?id=hfjSVIWViRUC&pg=RA1-PA890&lpg=RA1-PA890&dq=Wicklund〉.
|
| [2] |
P. Narayanaswami, M. Weiss, D. Selcen, W. David, E. Raynor, G. Carter, M. Wicklund, et al., Evidence-based guideline summary: diagnosis and treatment of limb- girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine, Neurology 83 (16) (2014) 1453-1463, https://doi.org/10.1212/wnl.0000000000000892.
|
| [3] |
Limb-Girdle Muscular Dystrophy (LGMD) - Diseases. ” Muscular Dystrophy Association. Dec 2015. 〈 https://www.mda.org/disease/limb-girdle-muscular- dystrophy〉.
|
| [4] |
H. Levison, Dystrophia musculorum progressiva; clinical and diagnostic criteria inheritance. Acta psychiatrica et neurologica scandinavica, Supplementum 76 (1951) 1-176 〈 https://pubmed.ncbi.nlm.nih.gov/14877599/〉.
|
| [5] |
S. Volker, A. Murphy, B. Udd, A. Corrado, S. Ayme, C. Bonneman, M. Visser, et al., 229th ENMC International Workshop:Limb Girdle Muscular Dystrophies - Nomenclature and Reformed Classification Naarden, the Netherlands, 17-19 March 2017, Neuromuscul. Disord. 28 (8) (2018) 702-710, https://doi.org/10.1016/j.nmd.2018.05.007.
|
| [6] |
M. Fanin, A.C. Nascimbeni, S. Aurino, E. Tasca, E. Pegoraro, V. Nigro, C. Angelini, Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes, Neurology 72 (16) (2009 Apr 21)1432-1435, https://doi.org/10.1212/WNL.0b013e3181a1885ePMID: 19380703.
|
| [7] |
Heng Li, Richard Durbin, Fast and accurate long-read alignment with burrows-wheeler transform, Bioinformatics 26 (5) (2010) 589-595, https://doi.org/10.1093/bioinformatics/btp698.
|
| [8] |
Laurence R.M., Zweig A.S., Hinrichs A.S., Karolchik D., Kuhn R.M., Wong M., Sloan C.A., et al. The UCSC Genome Browser Database: Extensions and Updates 2013. ”Nucleic Acids Research 41 (Database issue): D64-D69. https://doi.org/10.1093/nar/gks1048.
|
| [9] |
M.K. Aaron, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, et al., The genome analysis toolkit: A MapReduce framework for analyzing next- generation DNA sequencing data, Genome Res. 20 (9) (2010) 1297-1303, https://doi.org/10.1101/gr.107524.110.
|
| [10] |
H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, et al., The sequence Alignment/Map format and SAMtools, Bioinformatics 25 (16) (2009) 2078-2079, https://doi.org/10.1093/bioinformatics/btp352.
|
| [11] |
Donald F., Aldana R., Weber J.A., Edwards J.S. The Sentieon Genomics Tools - a Fast and Accurate Solution to Variant Calling from Next-Generation Sequence Data; March 2017. https://doi.org/10.1101/115717.
|
| [12] |
M.L. William, B. Pritchard, D. Rios, Y. Chen, P. Flicek, F. Cunningham, Deriving the consequences of genomic variants with the ensembl API and SNP effect predictor, Bioinformatics 26 (16) (2010) 2069-2070, https://doi.org/10.1093/bioinformatics/btq330.
|
| [13] |
J.K. Mah, L. Korngut, K.M. Fiest, J. Dykeman, L.J. Day, T. Pringsheim, N. Jette,A systematic review and meta-analysis on the epidemiology of the muscular dystrophies, Can. J. Neurol. Sci. / J. Can. Des. Sci. Neurol. 43 (1) (2015) 163-177, https://doi.org/10.1017/cjn.2015.311.
|
| [14] |
R. Thompson, V. Straub, Limb-Girdle Muscular Dystrophies - International Collaborations for Translational Research, Nat. Rev., Neurol. 12 (5) (2016) 294-309, https://doi.org/10.1038/nrneurol.2016.35.
|
| [15] |
SatishV. Khadilkar, Dayalal Faldu Hinaben, S. B. Patil, R. Singh, Limb-girdle muscular dystrophies in India: a review, Ann. Indian Acad. Neurol. 20 (2) (2017) 87, https://doi.org/10.4103/aian.aian_81_17.
|
| [16] |
S.V. Khadilkar, Chetan R. Chaudhari, S.Dastur Rashna, S.Gaitonde Pradnya, G.Yadav Jayendra, Limb-girdle muscular dystrophy in the Agarwals: utility of founder mutations in CAPN3 gene, Ann. Indian Acad. Neurol. 19 (1) (2016) 108, https://doi.org/10.4103/0972-2327.175435.
|
| [17] |
M. Fanin, C. Angelini, Progress and challenges in diagnosis of dysferlinopathy, Muscle Nerve 54 (5) (2016 Nov)821-835, https://doi.org/10.1002/mus.25367PMID: 27501525.
|
| [18] |
D. Baralle, M. Baralle, Splicing in action: assessing disease causing sequence changes, J. Med. Genet. 42 (10) (2005) 737-748, https://doi.org/10.1136/jmg.2004.029538.
|
| [19] |
I. Nilsson Mats, G.Macneil Lauren, Kitaoka Yu, F. Alqarni, R. Suri, M. Akhtar, M.E. Haikalis, et al., Redox state and mitochondrial respiratory chain function in skeletal muscle of LGMD2A patients, ” Ed. Jianhua Zhang. PLoS ONE 9 (7) (2014) e102549, https://doi.org/10.1371/journal.pone.0102549.
|
| [20] |
C. Mafalda, G. Numitone, S. Aurino, I.R. Caserta, M. Fanin, L. Politano, et al., Muscular dystrophy with marked dysferlin deficiency is consistently caused by primary dysferlin gene mutations, Eur. J. Hum. Genet. 19 (9) (2011) 974-980, https://doi.org/10.1038/ejhg.2011.70.
|
| [21] |
F.M. Harsini, S. Chebrolu, K.L. Fuson, Mark A. White, Anne M. Rice, R.Bryan Sutton, FerA is a membrane-associating four-helix bundle domain in the ferlin family of membrane-fusion proteins, Sci. Rep. 8 (1) (2018), https://doi.org/10.1038/s41598-018-29184-1.
|
| [22] |
S. Altin, A.R. Cole, C. Yeats, C. Orengo, N.H. Keep, Crystal structures of the human dysferlin inner DysF domain, BMC Struct. Biol. 14 (January) (2014) 3, https://doi.org/10.1186/1472-6807-14-3.
|
| [23] |
M. Krahn, B. Christophe, L. Véronique, N. Karine, B. Rafaelle, Bassez Guillaume, Figarella-Branger Dominique, et al., Analysis of the DYSF mutational spectrum in a large cohort of patients, Hum. Mutat. 30 (2) (2008) E345-E375, https://doi.org/10.1002/humu.20910.
|
| [24] |
J. Su-Qin, M. Yu, W. Zhang, He Lyu, Yun Yuan, Z.H. Wang, Dysferlin gene mutation spectrum in a large cohort of Chinese patients with dysferlinopathy, Chin. Med. J. 129 (19) (2016) 2287-2293, https://doi.org/10.4103/0366-6999.190671.
|
| [25] |
Q.R. Xiomara, J.M. Gastier-Foster, S. Lewis, M. Vinod, D.L. Thrush, C. Astbury, et al., Novel diagnostic features of dysferlinopathies, Muscle Nerve 42 (1) (2010) 14-21, https://doi.org/10.1002/mus.21650.
|
| [26] |
S. Gabriele, C. Simoncini, S. Giannotti, V. Zampa, C. Angelini, G. Ricci, Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages, Acta Myol.: Myopathies Cardiomyopathies 34 (1) (2015) 3-8 〈 https://pubmed.ncbi.nlm.nih.gov/26155063/〉.
|
| [27] |
N.E. Bengtsson, J.T. Seto, J.K. Hall, J.S. Chamberlain, G.L. Odom, Progress and prospects of gene therapy clinical trials for the muscular dystrophies, Hum. Mol. Genet. 25 (R1) (2015) R9-R17, https://doi.org/10.1093/hmg/ddv420.
|
PDF
(4265KB)
